NCT04526990: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above
- State
- Completed
- Phase
- Phase 3
- People
- 44,247 taking part
- Started
- 15 Sep 2020
- Primary completion
- 7 Aug 2021
- Arms
- Experimental group
- Results
- None posted
- Papers
- doi:10.1016/j.vaccine.2026.128378, doi:10.1016/j.vaccine.2026.128424, doi:10.1016/s0140-6736(21)02753-7
- 26 Aug 2020: Trial registered
- 15 Sep 2020: Trial started
- 21 Oct 2022: Trial completed